Hepatitis delta: In vitro evaluation of cytotoxicity and cytokines involved in PEG-IFN therapy

• Autores: Larissa Deadame de Figueiredo Nicolete, Celso Vladimiro Cunha, Mariana Tomazini Pinto, Evandra Strazza Rodrigues, Simone Kashima, Dimas Tadeu Covas, Juan Miguel Villalobos-Salcedo, Roberto Nicolete
• Ano de Publicação: 2020
• Journal: International Immunopharmacology

The treatment for hepatitis Delta virus (HDV) still consists of Pegylated interferon (PEG-IFN) combined with inhibitors of Hepatitis B virus (HBV) replication. In some patients may be occur a virological response, which means a negative HDV RNA 6 months after stopping treatment. In this study it was conducted an in vitro approach with the aim […]
Ler mais